In patients on V-A ECMO, highly significant changes in drug pharmacokinetics can occur by interactions with the ECMO support, drug characteristics, and patient characteristics.
← all excerpts
Population Pharmacokinetics of Amikacin in Patients on Veno-Arterial Extracorporeal Membrane Oxygenation.
1
—
—